July 1, 2026 · Form 4 insider transaction
Oelschlager Kristen M sold 400 shares of Castle Biosciences, Inc. at $24.78 per share, a transaction worth $9.9K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.; This transaction was executed in multiple trades at prices ranging from $24.77 to $24.79, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.